Skip to main content
ENSC logo

ENSC · Ensysce Biosciences, Inc. · Analyst Estimates

Track ENSC — free
$0.46 +0.01 (+1.24%) At close · Sep 18
Market Cap
$8.96M
Shares
19.46M

Analyst Estimates

Compare analyst forecasts for Ensysce Biosciences, Inc. across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-09-18 23:15 UTC · Publication dates shown per estimate · 16 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-1.09
-1.09
-1.09
-1.53
-1.98
-1.27
-3.54
EPS
analysts
Publication date not stated
1
0
0
1
1
Revenue
USD
Publication date not stated
4600000
4600000
4600000
Revenue
analysts
Publication date not stated
1

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-0.05
-0.05
-0.05
0.0
0.0
-0.11
0.0
EPS
analysts
Publication date not stated
1
0
0
0
0
Revenue
Publication date not stated
0
0
0
Revenue
analysts
Publication date not stated
0

Q ending 2026-09-30

Analyst estimates for Q ending 2026-09-30
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-0.19
-0.19
-0.19
0.09
-0.49
0.04
-0.69
EPS
analysts
Publication date not stated
1
0
0
1
1
Revenue
USD
Publication date not stated
1200000
1200000
1200000
Revenue
analysts
Publication date not stated
1

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-0.18
-0.18
-0.18
-0.6
-0.47
-0.29
-0.67
EPS
analysts
Publication date not stated
1
1
1
0
0
Revenue
USD
Publication date not stated
1200000
1200000
1200000
Revenue
analysts
Publication date not stated
1
Key facts CIK 1716947 CUSIP 293602504 13F (30d) 1 filings 1 filers Visit website Investor relations